FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Euphrosyne Gouzoulis-Mayfrank

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
J Mirić; M Bodatsch; Euphrosyne Gouzoulis-Mayfrank; P Häussermann
[A case of Bleuler's disease? 100 years of dementia praecox or group of schizophrenias].
Benjamin Becker; Katja Bender; Euphrosyne Gouzoulis-Mayfrank; Christoph Kabbasch; Philip Koester; Daniel Wagner; Joerg Daumann
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Philip Koester; Joerg Daumann
A prospective study of learning, memory, and executive function in new MDMA users.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Euphrosyne Gouzoulis-Mayfrank (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J Mirić; M Bodatsch; Euphrosyne Gouzoulis-Mayfrank; P Häussermann
[A case of Bleuler's disease? 100 years of dementia praecox or group of schizophrenias].
Der Nervenarzt 2013;84(3):381-5.
2013: Benjamin Becker; Katja Bender; Euphrosyne Gouzoulis-Mayfrank; Christoph Kabbasch; Philip Koester; Daniel Wagner; Joerg Daumann
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
Psychopharmacology 2013;225(4):923-34.
2013: Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Philip Koester; Joerg Daumann
A prospective study of learning, memory, and executive function in new MDMA users.
Addiction (Abingdon, England) 2013;108(1):136-45.
2012: P Koester; Marc Tittgemeyer; D Wagner; B Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Cortical thinning in amphetamine-type stimulant users.
Neuroscience 2012;221():182-92.
2012: Thomas Schnell; Joerg Daumann; Euphrosyne Gouzoulis-Mayfrank; Alexandra Kleiman; Benjamin Becker
Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL.
Schizophrenia research 2012;138(2-3):183-7.
2012: Andreas Bechdolf; C Ferber; C Geyer; J Güttgemanns; K Lindner; B Pohlmann; Euphrosyne Gouzoulis-Mayfrank
[State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial].
Der Nervenarzt 2012;83(7):888-96.
2011: Joerg Daumann; Philip Koester; Benjamin Becker; Daniel Wagner; Davide Imperati; Euphrosyne Gouzoulis-Mayfrank; Marc Tittgemeyer
Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry.
NeuroImage 2011;54(2):794-801.
2010: Joerg Daumann; D Wagner; Karsten Heekeren; Anna Neukirch; C M Thiel; Euphrosyne Gouzoulis-Mayfrank
Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis.
Journal of psychopharmacology (Oxford, England) 2010;24(10):1515-24.
2010: Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Interactions between specific parameters of cannabis use and verbal memory.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(6):871-6.
2010: Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Joerg Daumann
The impact of early-onset cannabis use on functional brain correlates of working memory.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(6):837-45.
2010: Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Joerg Daumann
Altered parahippocampal functioning in cannabis users is related to the frequency of use.
Psychopharmacology 2010;209(4):361-74.
2010: T Schnell; K Neisius; Joerg Daumann; Euphrosyne Gouzoulis-Mayfrank
[Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city].
Der Nervenarzt 2010;81(3):323-8.
2009: Thomas Schnell; Dagmar Koethe; Joerg Daumann; Euphrosyne Gouzoulis-Mayfrank
The role of cannabis in cognitive functioning of patients with schizophrenia.
Psychopharmacology 2009;205(1):45-52.
2009: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.
Dialogues in clinical neuroscience 2009;11(3):305-17.
2008: Joerg Daumann; Karsten Heekeren; Anna Neukirch; Christiane M Thiel; Walter Möller-Hartmann; Euphrosyne Gouzoulis-Mayfrank
Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis.
Psychopharmacology 2008;200(4):573-83.
2008: Knut Schnell; Karsten Heekeren; Joerg Daumann; Thomas Schnell; Ralph Schnitker; Walter Möller-Hartmann; Euphrosyne Gouzoulis-Mayfrank
Correlation of passivity symptoms and dysfunctional visuomotor action monitoring in psychosis.
Brain : a journal of neurology 2008;131(Pt 10):2783-97.
2008: Euphrosyne Gouzoulis-Mayfrank
[Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2008;36(4):245-53.
2008: Karsten Heekeren; Joerg Daumann; Anna Neukirch; Carsten Stock; Wolfram Kawohl; Christine Norra; Till D Waberski; Euphrosyne Gouzoulis-Mayfrank
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Psychopharmacology 2008;199(1):77-88.
2007: Euphrosyne Gouzoulis-Mayfrank; Maryam Balke; Soulmaz Hajsamou; Stephan Ruhrmann; Frauke Schultze-Lutter; Joerg Daumann; Karsten Heekeren
Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives.
Schizophrenia research 2007;97(1-3):35-42.
2007: Karsten Heekeren; Anna Neukirch; Joerg Daumann; Martina Stoll; Maja Obradovic; Karl-Artur Kovar; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
Journal of psychopharmacology (Oxford, England) 2007;21(3):312-20.
2007: Andy C Parrott; Raffaella M Milani; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(8):959-68.
2007: Knut Schnell; Karsten Heekeren; Ralf Schnitker; Joerg Daumann; Jochen Weber; Volker Hesselmann; Walter Möller-Hartmann; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
An fMRI approach to particularize the frontoparietal network for visuomotor action monitoring: Detection of incongruence between test subjects' actions and resulting perceptions.
NeuroImage 2007;34(1):332-41.
2006: Euphrosyne Gouzoulis-Mayfrank
[Doble diagnosis--psychosis and addiction].
Fortschritte der Neurologie-Psychiatrie 2006;74(9):528-44; quiz 545-6.
2006: Joerg Daumann; Bianca Till; Thomas Fischermann; Markus Rezk; Euphrosyne Gouzoulis-Mayfrank
Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Journal of psychopharmacology (Oxford, England) 2006;20(2):236-44.
2006: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Journal of psychopharmacology (Oxford, England) 2006;20(2):188-93.
2006: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Addiction (Abingdon, England) 2006;101(3):348-61.
2006: Euphrosyne Gouzoulis-Mayfrank; Karsten Heekeren; Anna Neukirch; Martina Stoll; Carsten Stock; Joerg Daumann; Maja Obradovic; Karl-Artur Kovar
Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(2):431-41.
2006: Euphrosyne Gouzoulis-Mayfrank; Susanne Arnold; Karsten Heekeren
Deficient inhibition of return in schizophrenia-further evidence from an independent sample.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(1):42-9.
2005: Andreas Bechdolf; B Pohlmann; C Geyer; C Ferber; Joachim Klosterkötter; Euphrosyne Gouzoulis-Mayfrank
[Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].
Fortschritte der Neurologie-Psychiatrie 2005;73(12):728-35.
2005: Euphrosyne Gouzoulis-Mayfrank; Karsten Heekeren; Anna Neukirch; Martina Stoll; C Stock; Maja Obradovic; Karl-Artur Kovar
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
Pharmacopsychiatry 2005;38(6):301-11.
2005: Joerg Daumann; Thomas Fischermann; Karsten Heekeren; Katharina Henke; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Psychopharmacology 2005;180(4):607-11.
2005: Euphrosyne Gouzoulis-Mayfrank; Thomas Fischermann; Markus Rezk; Bastian Thimm; Gernot Hensen; Joerg Daumann
Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Drug and alcohol dependence 2005;78(3):317-23.
2004: Rainer Thomasius; Euphrosyne Gouzoulis-Mayfrank; C Karus; H Wiedenmann; Leopold Hermle; Peter-Michael Sack; Dirk Zeichner; Udo Küstner; A Schindler; A Krüger; S Uhlmann; K U Petersen; Pavlina Zapletalova; Lutz Wartberg; C G Schütz; M Schulte-Markwort; Jost Obrocki; Andreas Heinz; Achim Schmoldt
[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
Fortschritte der Neurologie-Psychiatrie 2004;72(12):679-95.
2004: Ulrich Meincke; Dina Mörth; Tatjana Voss; Bernhard Thelen; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis--a longitudinal study.
European archives of psychiatry and clinical neuroscience 2004;254(6):415-21.
2004: Joerg Daumann; Thomas Fischermann; Karsten Heekeren; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Biological psychiatry 2004;56(5):349-55.
2004: Joerg Daumann; Thomas Fischermann; Ulrich Pilatus; Armin Thron; Walter Moeller-Hartmann; Euphrosyne Gouzoulis-Mayfrank
Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
Neuroscience letters 2004;362(2):113-6.
2004: Karsten Heekeren; Joerg Daumann; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.
Psychopharmacology 2004;173(3-4):418-24.
2004: Joerg Daumann; Gernot Hensen; Bastian Thimm; Markus Rezk; Bianca Till; Euphrosyne Gouzoulis-Mayfrank
Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Psychopharmacology 2004;173(3-4):398-404.
2004: Ulrich Meincke; Gregory A Light; Mark A Geyer; David L Braff; Euphrosyne Gouzoulis-Mayfrank
Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia.
Psychiatry research 2004;126(1):51-61.
2004: Euphrosyne Gouzoulis-Mayfrank; Karsten Heekeren; Tatjana Voss; Dina Moerth; Bernhard Thelen; Ulrich Meincke
Blunted inhibition of return in schizophrenia-evidence from a longitudinal study.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(2):389-96.
2004: Karsten Heekeren; Ulrich Meincke; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Attentional modulation of prepulse inhibition: a new startle paradigm.
Neuropsychobiology 2004;49(2):88-93.
2003: Euphrosyne Gouzoulis-Mayfrank; Tatjana Voss; Dina Mörth; Bernhard Thelen; Manfred Spitzer; Ulrich Meincke
Semantic hyperpriming in thought-disordered patients with schizophrenia: state or trait?--a longitudinal investigation.
Schizophrenia research 2003;65(2-3):65-73.
2003: Joerg Daumann; Ralph Schnitker; Jürgen Weidemann; Knut Schnell; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
Neuroreport 2003;14(15):1983-7.
2003: Euphrosyne Gouzoulis-Mayfrank; Bastian Thimm; Markus Rezk; Gernot Hensen; Joerg Daumann
Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(5):819-27.
2003: Joerg Daumann; Bruno Fimm; Klaus Willmes; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
Brain research. Cognitive brain research 2003;16(3):479-87.
2003: Ulrich Meincke; Rudolf Töpper; Euphrosyne Gouzoulis-Mayfrank
The electrically elicited R2 blink reflex consists of distinct subcomponents.
Electromyography and clinical neurophysiology 2003;43(2):91-5.
2002: Ulrich Meincke; Dina Mörth; Tatjana Voss; Euphrosyne Gouzoulis-Mayfrank
Electromyographical differentiation between the acoustic blink and startle reflex. Implications for studies investigating startle behavior.
European archives of psychiatry and clinical neuroscience 2002;252(3):141-5.
2002: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann; Henning Sass
[Chronic neurotoxic damage in ecstasy (MDMA) users. Review of the current state of research].
Der Nervenarzt 2002;73(5):405-21.
2002: Euphrosyne Gouzoulis-Mayfrank; Steffanie Becker; Susanne Pelz; Frank Tuchtenhagen; Joerg Daumann
Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?
Biological psychiatry 2002;51(9):766-9.
2002: Euphrosyne Gouzoulis-Mayfrank; Bernhard Thelen; S Maier; Karsten Heekeren; Karl-Artur Kovar; Henning Sass; Manfred Spitzer
Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
Neuropsychobiology 2002;45(4):205-12.
2001: Ulrich Meincke; Euphrosyne Gouzoulis-Mayfrank; Henning Sass
[The startle reflex in schizophrenia research].
Der Nervenarzt 2001;72(11):844-52.
2000: Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann; Frank Tuchtenhagen; Susanne Pelz; Steffanie Becker; Hanns Jürgen Kunert; Bruno Fimm; Henning Sass
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Journal of neurology, neurosurgery, and psychiatry 2000;68(6):719-25.
2000: Frank Tuchtenhagen; Joerg Daumann; Christine Norra; René Gobbelé; Steffanie Becker; Susanne Pelz; Henning Sass; Helmut Buchner; Euphrosyne Gouzoulis-Mayfrank
High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(6):608-17.
1999: Euphrosyne Gouzoulis-Mayfrank; Leopold Hermle; Karl-Artur Kovar; Henning Sass
[Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
Fortschritte der Neurologie-Psychiatrie 1999;67(12):574-6.
1999: Mathias Schreckenberger; Euphrosyne Gouzoulis-Mayfrank; Osama Sabri; Christian Arning; Michael Zimny; T Zeggel; Gudrun Wagenknecht; Hans-Juergen Kaiser; Henning Sass; Udalrich Buell
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study.
European journal of nuclear medicine 1999;26(12):1572-9.
1999: Euphrosyne Gouzoulis-Mayfrank; Mathias Schreckenberger; Osama Sabri; Christian Arning; Bernhard Thelen; Manfred Spitzer; Karl-Artur Kovar; Leopold Hermle; Udalrich Büll; Henning Sass
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(6):565-81.
1999: Euphrosyne Gouzoulis-Mayfrank; Bernhard Thelen; Elmar Habermeyer; Hanns Jürgen Kunert; Karl-Artur Kovar; H Lindenblatt; Leopold Hermle; Manfred Spitzer; Henning Sass
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.
Psychopharmacology 1999;142(1):41-50.
1998: Euphrosyne Gouzoulis-Mayfrank; Elmar Habermeyer; Leopold Hermle; A Steinmeyer; Hanns Jürgen Kunert; Henning Sass
Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study.
European psychiatry : the journal of the Association of European Psychiatrists 1998;13(8):399-406.
1998: M Brunnenberg; H Lindenblatt; Euphrosyne Gouzoulis-Mayfrank; Karl-Artur Kovar
Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection.
Journal of chromatography. B, Biomedical sciences and applications 1998;719(1-2):79-85.
1998: Euphrosyne Gouzoulis-Mayfrank; Karsten Heekeren; Bernhard Thelen; H Lindenblatt; Karl-Artur Kovar; Henning Sass; Mark A Geyer
Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.
Behavioural pharmacology 1998;9(7):561-6.
1998: Mathias Schreckenberger; Euphrosyne Gouzoulis-Mayfrank; Osama Sabri; Christian Arning; G Schulz; T Tuttass; Gudrun Wagenknecht; Hans-Juergen Kaiser; Henning Sass; Udalrich Buell
Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucose.
European journal of nuclear medicine 1998;25(11):1511-9.
1998: Euphrosyne Gouzoulis-Mayfrank; F Schneider; J Friedrich; Manfred Spitzer; Bernhard Thelen; Henning Sass
Methodological issues of human experimental research with hallucinogens.
Pharmacopsychiatry 1998;31 Suppl 2():114-8.
1998: Leopold Hermle; Euphrosyne Gouzoulis-Mayfrank; Manfred Spitzer
Blood flow and cerebral laterality in the mescaline model of psychosis.
Pharmacopsychiatry 1998;31 Suppl 2():85-91.
1998: Euphrosyne Gouzoulis-Mayfrank; Leopold Hermle; Bernhard Thelen; Henning Sass
History, rationale and potential of human experimental hallucinogenic drug research in psychiatry.
Pharmacopsychiatry 1998;31 Suppl 2():63-8.
1998: H Lindenblatt; E Krämer; P Holzmann-Erens; Euphrosyne Gouzoulis-Mayfrank; Karl-Artur Kovar
Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction.
Journal of chromatography. B, Biomedical sciences and applications 1998;709(2):255-63.
1998: Mathias Schreckenberger; Euphrosyne Gouzoulis-Mayfrank; Osama Sabri; Christian Arning; T Tuttass; G Schulz; Hans-Juergen Kaiser; Gudrun Wagenknecht; Henning Sass; Udalrich Büll
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study].
Nuklearmedizin. Nuclear medicine 1998;37(8):262-7.
1996: Leopold Hermle; Euphrosyne Gouzoulis-Mayfrank; M Spitzer
[Hallucinogen induced psychic disorders. Subjective experiences, psychopathology and differential diagnosis].
Fortschritte der Neurologie-Psychiatrie 1996;64(12):482-91.
1996: M Spitzer; M Thimm; Leopold Hermle; P Holzmann; Karl-Artur Kovar; H Heimann; Euphrosyne Gouzoulis-Mayfrank; U Kischka; F Schneider
Increased activation of indirect semantic associations under psilocybin.
Biological psychiatry 1996;39(12):1055-7.
1996: Euphrosyne Gouzoulis-Mayfrank; Leopold Hermle; Karl-Artur Kovar; Henning Sass
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Der Nervenarzt 1996;67(5):369-80.
1996: M Sohn; H Bosinski; Euphrosyne Gouzoulis-Mayfrank; H Ebel; S van Saldern; D Löffler; Gerhard Jakse
[Interdisciplinary concepts of surgical sex transformation in transsexual patients].
Der Urologe. Ausg. A 1996;35(1):26-34.
1994: Euphrosyne Gouzoulis-Mayfrank; J Kasper; H Grunze
[Generalized epileptic seizures in treatment with clozapine. Incidence, types, prognosis and recommendations with reference to therapeutic strategies].
Der Nervenarzt 1994;65(11):792-4.
1994: Euphrosyne Gouzoulis-Mayfrank; Leopold Hermle
[The dangers of "ecstasy"].
Der Nervenarzt 1994;65(9):648-50.